Cerebral abscess in a multiple sclerosis patient during treatment with natalizumab

被引:0
|
作者
B. Durmus
J. Van Goethem
A. Vercruyssen
G. De la Meilleure
C. Jadoul
B. Willekens
机构
[1] AZ Nikolaas,Department of Neurology
[2] AZ Nikolaas,Department of Radiology
[3] Moerlandstraat 1,Department of Neurology
[4] 9100,Laboratory of Experimental Hematology
[5] Department of Radiology,undefined
[6] Antwerp University Hospital,undefined
[7] Antwerp University Hospital,undefined
[8] University of Antwerp,undefined
来源
Acta Neurologica Belgica | 2020年 / 120卷
关键词
Natalizumab; Abscess; Bacterial infection; Multiple sclerosis; Immune system;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:215 / 217
页数:2
相关论文
共 50 条
  • [31] Does natalizumab have a role in the treatment of relapsing multiple sclerosis?
    Stangel, Martin
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (09): : 476 - 477
  • [32] Natalizumab Therapy for Multiple Sclerosis
    Derfuss, Tobias
    Kuhle, Jens
    Lindberg, Raija
    Kappos, Ludwig
    SEMINARS IN NEUROLOGY, 2013, 33 (01) : 26 - 36
  • [33] Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review
    Peng, Anjiao
    Qiu, Xiangmiao
    Zhang, Lin
    Zhu, Xi
    He, Shixu
    Lai, Wanlin
    Chen, Lei
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 396 : 202 - 205
  • [34] An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis
    Horga, Alejandro
    Castillo, Joaquin
    Rio, Jordi
    Tintore, Mar
    Auger, Cristina
    Sastre-Garriga, Jaume
    Carmen Edo, M.
    Perez-Miralles, Francisco
    Tur, Carmen
    Nos, Carlos
    Huerga, Elena
    Comabella, Manuel
    Rovira, Alex
    Montalban, Xavier
    REVISTA DE NEUROLOGIA, 2011, 52 (06) : 321 - 330
  • [35] Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
    Patti, Francesco
    Pappalardo, Angelo
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 45 - 51
  • [36] From injection therapies to natalizumab: views on the treatment of multiple sclerosis
    Bomprezzi, Roberto
    Okuda, Darin T.
    Alderazi, Yazan J.
    Stueve, Olaf
    Frohman, Elliot M.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2012, 5 (02) : 97 - 104
  • [37] Peptide Mimotope-Enabled Quantification of Natalizumab Arm Exchange During Multiple Sclerosis Treatment
    Page, Lesley J.
    Lagunas-Acosta, Jacqueline
    Heussen, Raphaela
    Castellana, Edward T.
    Messmer, Bradley T.
    THERAPEUTIC DRUG MONITORING, 2023, 45 (01) : 55 - 60
  • [38] Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab
    Verhaeghe, Alexander
    Deryck, Olivier Maurice
    Vanopdenbosch, Ludo J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (02) : 279 - 281
  • [39] Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
    Lee, De-Hyung
    Waschbisch, Anne
    Laemmer, Alexandra B.
    Doerfler, Arnd
    Schwab, Stefan
    Linker, Ralf A.
    JOURNAL OF NEUROINFLAMMATION, 2013, 10
  • [40] Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis
    Foley, Robert W.
    Tagg, Nathan T.
    Schindler, Matthew K.
    Fenton, Kaylan M.
    Reich, Daniel S.
    Cortese, Irene
    Mowry, Ellen M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (10) : 1424 - 1427